Biotech

All Articles

Novo inks $600M NanoVation bargain to research hereditary medicines ex-liver

.Novo Nordisk is continuing its press right into genetic medications, consenting to pay NanoVation R...

Innovent web links cytokine to intestines cancer feedbacks

.Innovent Biologics has made the situation that its gate inhibitor-cytokine combination protein poss...

Merck, Daiichi ADC reaches objective in phase 3 lung cancer research

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina strengthens artificial intelligence focus with collab to decide on cancer cells intendeds

.5 months after Rakovina Rehabs pivoted toward expert system, the cancer-focused biotech has actuall...

Ascendis' dwarfism drug favorites in phase 3, threatens BioMarin

.Ascendis Pharma has emerged as a prospective hazard to BioMarin's Voxzogo, reporting phase 3 growth...

Despite ph. 3 skip, Alkeus finds path ahead for eye health condition possession

.Though Alkeus Pharmaceuticals' dental eye condition property fell short to significantly minimize g...

Kairos goes public along with $6M IPO to fund trials of cancer cells medication

.With a triad of biotechs hitting the Nasdaq on Friday, it was very easy to miss out on a smaller-sc...

Vaccine as well as Keytruda combo reliable in squamous tissue carcinoma

.Immune system checkpoint preventions are actually the superheroes of cancer therapy. Medications li...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant management hirings, shootings and...

Regeneron's Opdualag competitor reveals 57% response rate

.Regeneron is actually back along with lasting follow-up for its LAG-3 prevention as well as PD-1 in...